Spark Therapeutics Expands Visionary Leadership with Appointment of Michael Retterath as Chief Strategy Officer
PHILADELPHIA, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY)...
Staff
Reflect Scientific Inc. Announces Third Quarter 2020 Financial Results
OREM, Utah, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
RAPT Therapeutics Reports Positive Initial Data from Ongoing Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications
-Evidence of Monotherapy and Combination Activity in Charged Tumor Types--Company Advances Several Cohorts into Phase 2 Expansions--Conference Call and Webcast...
Biogen Ranked #1 Biotechnology Company by Dow Jones Sustainability World Index for an Industry Record 5th Time; Recognition Reflects Longstanding ESG Leadership
Biogen earns top scores on areas including access to medicine, talent attraction, innovation management and climate performance and reporting In...
Progenity to Participate in the 32nd Annual Piper Sandler Healthcare Conference
SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record...
XOMA Earns $2 Million Milestone from Takeda as Mezagitamab Advances into Phase 2 Development
EMERYVILLE, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has...
Otonomy to Participate in Two Upcoming Investor Conferences
SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative...
Cytokinetics Announces Preclinical Data for CK-3773274 and CK-3772271 Presented at the AHA Scientific Sessions 2020
New Findings from Studies of Cardiac Myosin Inhibitors in Animal Models of Hypertrophic Cardiomyopathy and Heart Failure with Preserved Ejection...
Crinetics Pharmaceuticals Appoints Acromegaly Expert, Peter Trainer, Vice President of Clinical Endocrinology
SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on...
Venus Concept Announces Third Quarter and First Nine Months of 2020 Financial Results
TORONTO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
Cytokinetics Announces Presentations Related to Health Economics and Outcomes Research in Heart Failure and Hypertrophic Cardiomyopathy at the AHA Scientific Sessions 2020
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that new findings from...
Myriad Genetics Announces Global Expansion of Myriad myChoice® Tumor Testing in Europe and China
SALT LAKE CITY, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics...
MediPharm Labs Reports Third Quarter 2020 Results
BARRIE, Ontario, Nov. 16, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or...
Masimo to Present in Stifel Virtual Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Stifel Virtual Healthcare Conference...
Model N’s Fall 2020 Release for High Tech Offers Expanded AI/ML, Price Optimization and Channel Network Features
Model N introduces new revenue management and channel performance solutions with enhanced AI/ML reach for deal and channel intelligence SAN...
InterVenn Biosciences Raises $34M to Commercialize Glycoproteomic LDT for Ovarian Cancer and Immuno-oncology; taps John Leite, Ph.D., as Chief Business Officer
Company looks to validate first of its kind LDTs intended for immediate clinical use and drive rapidly expanding partnership projects...
Accenture, Orexo Team to Offer Digital Therapeutics Through INTIENT™ Platform
NEW YORK & MORRISTOWN, N.J.--(BUSINESS WIRE)--Accenture (NYSE: ACN) has helped the U.S. subsidiary of Swedish pharmaceutical company Orexo launch its...
Frequency Therapeutics Provides Business Updates and Reports Third Quarter 2020 Financial Results
Day-90 Analysis of FX-322 Phase 2a Study for Acquired Sensorineural Hearing Loss (SNHL) Planned for Late Q1 2021; End of...
Grapefruit USA, Inc. Reports 677% Revenue Growth Year-Over-Year; 48% Revenue Growth QuarterOver-Quarter, Margins Expand; CEO Recaps Overall Incredible Quarter
LOS ANGELES, CA and DESERT HOT SPRINGS, CA / ACCESSWIRE / November 16, 2020 / Grapefruit USA, Inc., ("GPFT", "Grapefruit"...
Study Investigates Effects of Patient Blood Management Program with Masimo SpHb®, Noninvasive, Continuous Hemoglobin Monitoring, on Postoperative Cancer Patients
Patient Blood Management with Masimo SpHb Increased Transfusion Appropriateness and Decreased RBC Units Transfused per Patient NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ:...